Show simple item record

dc.contributor.authorExecutive Board, 55
dc.coverage.spatialGenevaEN
dc.date.accessioned2015-01-16T13:43:13Z
dc.date.available2015-01-16T13:43:13Z
dc.date.issued1974
dc.identifier.govdocEB55/12
dc.identifier.urihttp://www.who.int/iris/handle/10665/148557
dc.description(‎Provisional agenda item 2.12)‎EN
dc.language.isoenEN
dc.publisherWorld Health OrganizationEN
dc.subjectPharmaceutical productsEN
dc.subject.meshPharmaceutical PreparationsEN
dc.subject.meshDrug Delivery SystemsEN
dc.subject.meshDeveloping CountriesEN
dc.subject.meshNational Health ProgramsEN
dc.subject.meshHealth PolicyEN
dc.subject.meshDrug IndustryEN
dc.subject.meshResearchEN
dc.subject.meshMarketingEN
dc.subject.meshLegislation, DrugEN
dc.subject.meshGovernment RegulationEN
dc.subject.meshQuality ControlEN
dc.subject.meshDrugs, GenericEN
dc.subject.meshDrug CostsEN
dc.subject.meshHealth Knowledge, Attitudes, PracticeEN
dc.subject.meshInternational CooperationEN
dc.titleProphylactic and therapeutic substances: report by the Director-GeneralEN
dc.typeGoverning body documentsEN
dc.subject.meshqualifierstandardsEN


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record